Analyst Ratings for Ocular Therapeutix (OCUL)
OCUL Rating Summary
OCUL Price Target Summary
- Highest: $31.00 (Piper Sandler)
- Lowest: $18.00 (Needham)
- Average: $24.55
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$24.55 (+139%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
Avg. $ Target:
$24.55 (+139%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2025 | Chardan | Daniil Gataulin | New Coverage | Buy (N/A) |
21.00 (N/A) |
12.81 (10.27) |
-19.83% | Details |
| 4/8/2025 | William Blair » Updated 3/2/2026 |
Lachlan Hanbury-Brown | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.30 (10.27) |
63.02% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
